- Home
- NEOV vs XBIT Comparison
NEOV vs XBIT Comparison
Compare NEOV & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NEOV | XBIT |
|---|---|---|
| Founded | 2018 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Pharmaceuticals and Biotechnology |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 129.2M | 69.5M |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | NEOV | XBIT |
|---|---|---|
| Price | $3.77 | $2.44 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 232.3K | 73.6K |
| Earning Date | 11-10-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $14,486,857.00 | N/A |
| Revenue This Year | $148.14 | N/A |
| Revenue Next Year | $6.34 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 486.23 | N/A |
| 52 Week Low | $1.80 | $2.09 |
| 52 Week High | $6.19 | $7.24 |
Technical Indicators
Market Signals| Indicator | NEOV | XBIT |
|---|---|---|
| Relative Strength Index (RSI) | 42.08 | 48.15 |
| Support Level | $3.35 | $2.15 |
| Resistance Level | $3.93 | $2.65 |
| Average True Range (ATR) | 0.35 | 0.15 |
| MACD | -0.03 | 0.02 |
| Stochastic Oscillator | 27.83 | 33.33 |
Price Performance
Historical ComparisonAbout NEOV NeoVolta Inc.
NeoVolta Inc is engaged in designing, manufacturing and sale of high end Energy Storage System which can store and use solar energy via batteries and an inverter at a residential site. Its market place includes solar industry, installers, new construction homebuilders, home remodelers and homeowners.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.